SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.53    -0.002 (-0.38%)
Bid:
0.51
Ask:
0.528
Spread: 0.018 (3.529%)
Market Cap: $308.10m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

TR1 Notification

10 Dec 2019 12:47

RNS Number : 3961W
Integrated Diagnostics Holdings PLC
10 December 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Integrated Diagnostic Holdings Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Intra-group reorganisation

X

3. Details of person subject to the notification obligationiv See Section 9

Name

Actis LLP

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Actis IDH B.V. (outgoing shareholder)

City and country of registered office (if applicable)

Amsterdam, The Netherlands

Name

Actis IDH Limited (incoming shareholder)

City and country of registered office (if applicable)

St Peter Port, Guernsey

5. Date on which the threshold was crossed or reachedvi:

06/12/2019

6. Date on which issuer notified (DD/MM/YYYY):

06/12/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

21.00%

0.00%

21.00%

150,000,000

Position of previous notification (if

applicable)

21.00%

0.00%

21.00%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ISIN: JE00BV9H9G76

31,500,000

0

21.00%

0.00%

SUBTOTAL 8. A

31,500,000

21.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 LP)

8.32%

0

8.32%

Actis Global 4 LP

8.32%

0

8.32%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 A LP)

2.67%

0

2.67%

Actis Global 4 A LP

2.67%

0

2.67%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Global 4 C LP)

0.83%

0

0.83%

Actis Global 4 C LP

0.83%

0

0.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 LP)

4.54%

0

4.54%

Actis Africa 4 LP

4.54%

0

4.54%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis GP LLP (as general partner of Actis Africa 4 A LP)

3.83%

0

3.83%

Actis Africa 4 A LP

3.83%

0

3.83%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

Actis LLP

21.00%

0

21.00%

Actis Guernsey GP Limited (as general partner of Actis 4 Co-Investment Scheme LP)

0.81%

0

0.81%

Actis 4 Co-Investment Scheme LP

0.81%

0

0.81%

Actis 4 PCC - Cell Mauritius IDH

21.00%

0

21.00%

B.V. Actis IDH Holding S.A.R.L (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH B.V. (outgoing as part of reorganisation)

21.00%

0

21.00%

Actis IDH Limited (incoming as part of reorganisation)

21.00%

0

21.00%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

As announced on 31 December 2018 by Integrated Diagnostics Holdings plc, Actis IDH B.V., a holding company ultimately controlled by Actis GP LLP in its capacity as the General Partner of each of the limited partnerships comprising Actis Global 4 and Actis Africa 4, and which holds a 21% shareholding in the Integrated Diagnostics Holdings plc, has transferred its entire shareholding in Integrated Diagnostics Holdings plc to its affiliate, Actis IDH Limited, as result of an intra-group reorganisation. Actis IDH Limited is also ultimately controlled by Actis GP LLP.

 

Place of completion

Jersey

Date of completion

06/12/2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLBDBDDDSBBGCG
Date   Source Headline
28th May 20205:11 pmRNSAnnual Financial Report & Notice of AGM
28th Apr 20207:00 amRNSFinal Results
24th Apr 202011:26 amRNSNotice of Results
25th Mar 20207:00 amRNSCovid-19 Trading Update
23rd Mar 20207:00 amRNSDelay of results pursuant to request of FCA
20th Mar 20203:03 pmRNSNotice of Results
19th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202010:10 amRNSNotice of Results
13th Jan 20204:40 pmRNSSecond Price Monitoring Extn
13th Jan 20204:35 pmRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSChange of Adviser
10th Dec 201912:47 pmRNSTR1 Notification
5th Dec 20194:35 pmRNSPrice Monitoring Extension
27th Nov 20197:00 amRNS3rd Quarter Results
16th Oct 20194:40 pmRNSSecond Price Monitoring Extn
16th Oct 20194:35 pmRNSPrice Monitoring Extension
10th Sep 20197:00 amRNSHalf-year Report
9th Sep 201910:19 amRNSNotice of Results - Analysts Invitation
28th Aug 20194:40 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
27th Aug 20194:41 pmRNSSecond Price Monitoring Extn
27th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20193:40 pmRNSNotice of Results
12th Jun 20194:41 pmRNSSecond Price Monitoring Extn
12th Jun 20194:35 pmRNSPrice Monitoring Extension
15th May 201912:21 pmRNSReplacement - 1st Quarter Results
15th May 20197:00 amRNS1st Quarter Results
14th May 20194:14 pmRNSResult of AGM
18th Apr 20195:42 pmRNSAnnual Financial Report & Notice of AGM
21st Mar 20197:00 amRNSFinal Results
7th Mar 20197:00 amRNSAppointment of a Broker
5th Mar 20197:00 amRNSNotice of Results
1st Mar 20194:09 pmRNSHolding(s) in Company
31st Dec 20181:27 pmRNSHolding(s) in Company
17th Dec 20189:06 amRNSAgreement with Georgia Healthcare Group
21st Nov 20187:00 amRNS3rd Quarter Results
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
16th Aug 20187:00 amRNSHalf-year Report
14th Aug 20189:46 amRNSLaunch of radiology business in Egyptian market
9th Aug 20184:35 pmRNSPrice Monitoring Extension
5th Jul 20184:35 pmRNSPrice Monitoring Extension
15th May 20187:00 amRNSTrading Statement
14th May 20184:25 pmRNSResult of AGM
11th May 20184:46 pmRNSHolding(s) in Company
25th Apr 20184:35 pmRNSPrice Monitoring Extension
19th Apr 20185:04 pmRNSAnnual Financial Report & Notice of AGM
12th Apr 201812:08 pmRNSSecond Price Monitoring Extn
12th Apr 201812:02 pmRNSPrice Monitoring Extension
9th Apr 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.